Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma
- 1 April 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (4) , 834-842
Abstract
The growth of any solid tumor depends on angiogenesis. Among the known angiogenic factors, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), are potent and representative factors involved in tumor development. It has been reported that bFGF and VEGF showed a synergistic effect in both in vitro and in vivo angiogenesis. However, the interaction of these factors on tumor development and angiogenesis, including hepatocellular carcinoma (HCC), has not yet been elucidated. In this study, we examined the combined effect of bFGF and VEGF overexpression by means of a combination of a retroviral tetracycline (tet)-regulated (Retro-Tet) gene expression system, which can manipulate the gene expression in vivo by providing tet in the drinking water, and a conventional plasmid gene expression system. In an allograft study, bFGF and VEGF overexpression synergistically increased tumor growth and angiogenesis in the murine HCC cells. This synergistic effect also was found in established tumors. VEGF messenger RNA (mRNA) expression in the tumor was increased 3.1-fold by bFGF-overexpression, and the bFGF-induced tumor development was significantly attenuated by treatment with KDR/Flk-1 neutralizing monoclonal antibody. In conclusion, these results suggest that bFGF synergistically augments VEGF-mediated HCC development and angiogenesis at least partly by induction of VEGF through KDR/Flk-1.Keywords
This publication has 36 references indexed in Scilit:
- Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesisOncogene, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Tumor angiogenesis: past, present and the near futureCarcinogenesis, 2000
- Fibroblast growth factor-2The International Journal of Biochemistry & Cell Biology, 2000
- TUMOUR ANGIOGENESISThe Journal of Pathology, 1996
- Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994
- Fibroblast Growth FactorClinical Orthopaedics and Related Research, 1990
- Fibroblast growth factor: Structural and biological propertiesJournal of Cellular Physiology, 1987